The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D002738:Chloroquine / Q000494:pharmacology; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000469:parasitology; D008297:Male; D015767:Mefloquine; D051379:Mice; D010880:Piperidines / Q000494:pharmacology*; D010962:Plasmodium berghei / Q000187:drug effects*; D011739:Pyrimethamine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D013413:Sulfadoxine / Q000494:pharmacology
D000962:Antimalarials; D004338:Drug Combinations; D010880:Piperidines; D011804:Quinolines; D013413:Sulfadoxine; D002738:Chloroquine; D015767:Mefloquine; D011739:Pyrimethamine